Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Apr 7, 2022
Insider Transaction Report
Form 4
Transactions
- Award
Stock Options (Right to Buy)
2022-04-05+124,138→ 124,138 totalExercise: $25.75Exp: 2032-04-05→ Common Stock (124,138 underlying) - Award
Restricted Stock Units
2022-04-05+36,174→ 36,174 total→ Common Stock (36,174 underlying) - Award
Restricted Stock Units
2022-04-05+144,695→ 144,695 total→ Common Stock (144,695 underlying)
Footnotes (4)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning April 5, 2023.
- [F4]Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.